Dell Inc postponed its meeting on CEO Michael Dell's USD 24.4 billion buyout offer to July 24, buying time to solicit more proxy votes and drum up more support despite winning shareholders at the eleventh hour.
A special committee set up by Taro Pharma board to review Sun Pharma‘s buyout offer has rejected the offer as inadequate, eight months after the offer was made, reports Archana Shukla of CNBC-TV18.